GREEN JOHN B 4
4 · Dicerna Pharmaceuticals Inc · Filed Nov 27, 2019
Insider Transaction Report
Form 4
GREEN JOHN B
Interim CFO
Transactions
- Exercise/Conversion
Common Stock
2019-11-25$5.45/sh+12,500$68,125→ 23,198 total - Sale
Common Stock
2019-11-25$24.95/sh−12,500$311,875→ 10,698 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-25−12,500→ 227,500 totalExercise: $5.45Exp: 2026-04-14→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2018.
- [F3]The option vested 25% after the first year anniversary of the vesting start date of April 14, 2016 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.